Kaveri Pohlman
Stock Analyst at BTIG
(0.20)
# 4,123
Out of 4,827 analysts
21
Total ratings
15%
Success rate
-32.73%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kaveri Pohlman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MGNX MacroGenics | Downgrades: Neutral | n/a | $1.54 | - | 4 | Aug 1, 2024 | |
| GMAB Genmab | Maintains: Buy | $46 → $47 | $19.42 | +142.02% | 3 | Jun 27, 2024 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $20 → $30 | $7.77 | +286.10% | 2 | Apr 17, 2024 | |
| XNCR Xencor | Maintains: Buy | $56 → $38 | $8.79 | +332.31% | 1 | Apr 16, 2024 | |
| NUVB Nuvation Bio | Upgrades: Buy | $5 | $2.10 | +138.10% | 2 | Mar 26, 2024 | |
| JANX Janux Therapeutics | Initiates: Buy | $62 | $26.37 | +135.12% | 1 | Mar 21, 2024 | |
| PYXS Pyxis Oncology | Initiates: Buy | $8 | $1.09 | +633.94% | 1 | Feb 9, 2024 | |
| EXEL Exelixis | Initiates: Buy | $27 | $36.50 | -26.03% | 1 | Dec 19, 2023 | |
| RCUS Arcus Biosciences | Reiterates: Buy | $70 | $8.53 | +720.63% | 1 | Aug 23, 2023 | |
| STTK Shattuck Labs | Initiates: Buy | $12 | $0.95 | +1,166.89% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $8 | $1.09 | +633.94% | 2 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12,320 → $4,928 | $1.29 | +381,915.50% | 2 | Feb 9, 2022 |
MacroGenics
Aug 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.54
Upside: -
Genmab
Jun 27, 2024
Maintains: Buy
Price Target: $46 → $47
Current: $19.42
Upside: +142.02%
Cullinan Therapeutics
Apr 17, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $7.77
Upside: +286.10%
Xencor
Apr 16, 2024
Maintains: Buy
Price Target: $56 → $38
Current: $8.79
Upside: +332.31%
Nuvation Bio
Mar 26, 2024
Upgrades: Buy
Price Target: $5
Current: $2.10
Upside: +138.10%
Janux Therapeutics
Mar 21, 2024
Initiates: Buy
Price Target: $62
Current: $26.37
Upside: +135.12%
Pyxis Oncology
Feb 9, 2024
Initiates: Buy
Price Target: $8
Current: $1.09
Upside: +633.94%
Exelixis
Dec 19, 2023
Initiates: Buy
Price Target: $27
Current: $36.50
Upside: -26.03%
Arcus Biosciences
Aug 23, 2023
Reiterates: Buy
Price Target: $70
Current: $8.53
Upside: +720.63%
Shattuck Labs
Aug 31, 2022
Initiates: Buy
Price Target: $12
Current: $0.95
Upside: +1,166.89%
Jul 7, 2022
Maintains: Buy
Price Target: $16 → $8
Current: $1.09
Upside: +633.94%
Feb 9, 2022
Maintains: Buy
Price Target: $12,320 → $4,928
Current: $1.29
Upside: +381,915.50%